期刊文献+

CYP2C18基因多态性对瓣膜置换术后服用华法林剂量的影响研究 被引量:1

Research on influencing of CYP2C18 gene polymorphism on warfarin dose after valve replacement surgery
下载PDF
导出
摘要 目的探讨云贵高原汉族人群细胞色素P450(CYP)2C18、维生素K环氧化物还原酶复合体亚单位1(VKORC1)、CYP2C9的基因型分布情况及其基因多态性与华法林稳定剂量的相关性。方法以2011年1月至2014年1月在该院行瓣膜置换术后持续服用华法林抗凝治疗的云贵高原汉族患者176例为研究对象,采集静脉血检测各位点基因型,分析基因型及等位基因频率分布,以及基因多态性与华法林稳定剂量的相关性。结果各位点基因型及等位基因频率分布均符合Hardy-Winberg遗传平衡(P>0.05);CYP2C18(rs7896133)、VKORC1(rs9923231)、CYP2C9(rs1057910)、CYP2C9(rs4086116)基因位点的基因多态性与华法林稳定剂量相关(P<0.05)。结论云贵高原汉族患者CYP2C18(rs7896133)、VKORC1(rs9923231)、CYP2C9(rs1057910)、CYP2C9(rs4086116)基因多态性可能是华法林稳定剂量个体差异的影响因素。 Objective To investigate the CYP2C18,VKORC1 and CYP2C9 genotype distribution situation and the correlation between their polymorphism with warfarin stable dose. Methods A total of 176 Yungui plateau Han patients with continuously warfarin anticoagulation therapy after valve replacement in this hospital from January 201t to January 2014 served as the research subjects. The venous blood was collected for detecting genotypes at various loci. The genotype and allele frequency distribution were analyzed,and the correlation between the gene polymorPhism with warfarin stable dose was analyzed. Results The genotypes and allele frequencies at various loci conformed to the Hardy-Winberg genetic balance (P〉0.05). The polymorphisms of CYP2C18 (rs7896133) ,VKORC1 (rs9923231),CYP2C9(rs1057910) and CYP2C9(rs4086116) gene loci were correlated with warfarin stable dose (P〉0.05). Conclusion The gene polymorphism of CYP2C18(rs7896133) ,VKORC1 (rs9923231) ,CYP2Cg(rs1057910) and CYP2C9(rs4086116) in Yungui plateau Han patients may be the influence factors which contribute to warfarin stable dose personalized difference.
出处 《重庆医学》 CAS 北大核心 2017年第35期4974-4976,共3页 Chongqing medicine
基金 云南省科技厅-昆明医科大学应用基础研究联合专项资金项目(201501UH00141)
关键词 多态性 单核苷酸 华法林 瓣膜置换术 CYP2C18 polymorphism,single nucleotide warfarin valve replacement surgery CYP2C18
  • 相关文献

参考文献5

二级参考文献74

  • 1芮建中,张震,李金恒.群体药代动力学/群体药效动力学原理及研究方法[J].医学研究生学报,2005,18(3):246-249. 被引量:34
  • 2陈守宏,陈艳,朱波.益气活血方对房颤患者凝血功能的影响[J].陕西中医,2005,26(7):640-641. 被引量:7
  • 3AITHAL G P, DAY C P, KESTEVEN P J, et al. Association of polymorphisms in the cytoehrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications[ J]. Lancet, 1999 353(8) : 717 -719.
  • 4LI T, CHANG C Y, JIN D Y, et al. Identification of the gene for vi- tamin K epoxide reductase[J]. Nature, 2004, 427(12) : 541 -544.
  • 5CAVALLARI L H, MOMARY K M, PATEL S R, et al. Pharma- cogenomics of warfarin dose requirements in hispanics[ J]. Blood Ceils Mole and Dis, 2011,46(8) : 147 - 150.
  • 6MIAO L, YANG J, HUANG C, et al. Contribution of age, body weight, and CYP2C9 and VKORCI genotype to the anticoagulant response to warfarin : proposal for a new dosing regimen in Chinese patients[J]. Eur J Clin Pharmacol, 2007, 63(4) : 1135 - 1141.
  • 7YANG J, HUANG C, SHEN Z, et al. Contribution of 1173C > T polymorphism in the VKORC1 gene to warfarin dose requirements in Han Chinese patients receiving antieoagulation [ J ]. Int J Clin Pharmacology Ther, 2011,49( 1 ) : 23 - 29.
  • 8D'ANDREA G, D'AMBROSIO R L, DI PERNA P, et al. A poly- morphism in the VKORC1 gene is associated with an interindividu-al variability in the dose - anticoagulant effect of warfarin [J]. Blood, 2005, 105(2): 645-649.
  • 9BORGIANI P, CICCACCI C, FORTE V, et al. Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians [J]. Pharma- cogenomics, 2007, 8( 11 ) : 1545 - 1550.
  • 10CARLQUIST J F, HORNE B D, MOWER C, et al. An evaluation of nine genetic variants related to metabolism and mechanism of ac- tion of warfarin as applied to stable dose prediction[ J]. J Thromb Thrombolysis, 2010, 30 (7) : 358 - 364.

共引文献16

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部